<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2205551-B1" country="EP" doc-number="2205551" kind="B1" date="20140108" family-id="39689230" file-reference-id="270075" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146588196" ucid="EP-2205551-B1"><document-id><country>EP</country><doc-number>2205551</doc-number><kind>B1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-08746586-A" is-representative="NO"><document-id mxw-id="PAPP154850388" load-source="docdb" format="epo"><country>EP</country><doc-number>08746586</doc-number><kind>A</kind><date>20080423</date><lang>EN</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140552273" ucid="US-2008061194-W" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>2008061194</doc-number><kind>W</kind><date>20080423</date></document-id></priority-claim><priority-claim mxw-id="PPC140553423" ucid="US-92638607-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>92638607</doc-number><kind>P</kind><date>20070426</date></document-id></priority-claim></priority-claims><dates-of-public-availability><intention-to-grant-date><date>20130724</date></intention-to-grant-date></dates-of-public-availability><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989324938" load-source="docdb">C07C 213/08        20060101AFI20130705BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989324939" load-source="docdb">C07C 217/40        20060101ALI20130705BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL1989645164" load-source="docdb" scheme="CPC">C07C 213/08        20130101 FI20130101BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132369221" lang="DE" load-source="patent-office">VERFAHREN ZUR HERSTELLUNG VON AMINODIALKOXYALDEHYDEN DURCH HYDROFORMYLIERUNG</invention-title><invention-title mxw-id="PT132369222" lang="EN" load-source="patent-office">METHOD OF PRODUCING AMINO DIALKOXY ALDEHYDES VIA HYDROFORMYLATION</invention-title><invention-title mxw-id="PT132369223" lang="FR" load-source="patent-office">PROCÉDÉ DE PRODUCTION D'ALDEHYDES AMINO DIALCOXYLÉS PAR LE BIAIS DE L'HYDROFORMYLATION</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR919523288" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>REDDY S LAB EU LTD DR</last-name><address><country>GB</country></address></addressbook></applicant><applicant mxw-id="PPAR919539416" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>DR. REDDY'S LABORATORIES (EU) LIMITED</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919510695" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>COBLEY CHRISTOPHER</last-name><address><country>GB</country></address></addressbook></inventor><inventor mxw-id="PPAR919545386" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>COBLEY, CHRISTOPHER</last-name></addressbook></inventor><inventor mxw-id="PPAR919021987" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>COBLEY, CHRISTOPHER</last-name><address><street>43 Park Avenue Cambridge</street><city>Cambs CB4 9JU</city><country>GB</country></address></addressbook></inventor><inventor mxw-id="PPAR919517019" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>RAND CYNTHIA L</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919527510" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>RAND, CYNTHIA, L.</last-name></addressbook></inventor><inventor mxw-id="PPAR919021986" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>RAND, CYNTHIA, L.</last-name><address><street>230 Barden Road</street><city>Sanford, MI 48657</city><country>US</country></address></addressbook></inventor></inventors><assignees><assignee mxw-id="PPAR919021988" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Dr. Reddy's Laboratories (EU) Limited</last-name><iid>101061300</iid><address><street>Riverview Road</street><city>Beverley East Yorkshire HU17 0LD</city><country>GB</country></address></addressbook></assignee></assignees><agents><agent mxw-id="PPAR919021989" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Raynor, John</last-name><iid>100020113</iid><address><street>Beck Greener Fulwood House 12 Fulwood Place</street><city>London WC1V 6HR</city><country>GB</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="US-2008061194-W"><document-id><country>US</country><doc-number>2008061194</doc-number><kind>W</kind><date>20080423</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2008134327-A1"><document-id><country>WO</country><doc-number>2008134327</doc-number><kind>A1</kind><date>20081106</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS549890302" load-source="docdb">AT</country><country mxw-id="DS549868029" load-source="docdb">BE</country><country mxw-id="DS549870919" load-source="docdb">BG</country><country mxw-id="DS549782537" load-source="docdb">CH</country><country mxw-id="DS549874730" load-source="docdb">CY</country><country mxw-id="DS549890303" load-source="docdb">CZ</country><country mxw-id="DS549868034" load-source="docdb">DE</country><country mxw-id="DS549874731" load-source="docdb">DK</country><country mxw-id="DS549874732" load-source="docdb">EE</country><country mxw-id="DS549923086" load-source="docdb">ES</country><country mxw-id="DS549870920" load-source="docdb">FI</country><country mxw-id="DS549783590" load-source="docdb">FR</country><country mxw-id="DS549868035" load-source="docdb">GB</country><country mxw-id="DS549874733" load-source="docdb">GR</country><country mxw-id="DS549868036" load-source="docdb">HR</country><country mxw-id="DS549890304" load-source="docdb">HU</country><country mxw-id="DS549782538" load-source="docdb">IE</country><country mxw-id="DS549874734" load-source="docdb">IS</country><country mxw-id="DS549783591" load-source="docdb">IT</country><country mxw-id="DS549874735" load-source="docdb">LI</country><country mxw-id="DS549870921" load-source="docdb">LT</country><country mxw-id="DS549799742" load-source="docdb">LU</country><country mxw-id="DS549870930" load-source="docdb">LV</country><country mxw-id="DS549870931" load-source="docdb">MC</country><country mxw-id="DS549799743" load-source="docdb">MT</country><country mxw-id="DS549782539" load-source="docdb">NL</country><country mxw-id="DS549923087" load-source="docdb">NO</country><country mxw-id="DS549782540" load-source="docdb">PL</country><country mxw-id="DS549799744" load-source="docdb">PT</country><country mxw-id="DS549783592" load-source="docdb">RO</country><country mxw-id="DS549782545" load-source="docdb">SE</country><country mxw-id="DS549890309" load-source="docdb">SI</country><country mxw-id="DS549923088" load-source="docdb">SK</country><country mxw-id="DS549870932" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><description mxw-id="PDES63960624" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001"><u>Field of the Invention</u></heading><p id="p0001" num="0001">The present invention is a method of producing ami no dialkoxy compounds, including particularly 4-aminobutyraldehyde dialkyl acetal.</p><heading id="h0002"><u>Background of the Invention</u></heading><p id="p0002" num="0002">Amino dialkoxy compounds have utility as bifunctional synthetic intermediates for use in pharmaceutical, agrochemical, fragrance chemical and other fine chemical applications. Compositions having a low purity (about 90%) 4-aminobutyraldehyde diethyl acetal are available commercially for example from Sigma-Aldrich. Most previous methods of making this compound involve reduction of a nitrile functionality to access the primary amine - a step that is either susceptible to catalyst poisoning via trace quantities of contaminants or involves stoichiometric hydride reducing agents. See e.g. <patcit id="pcit0001" dnum="US5886227A"><text>U.S. 5,886,227</text></patcit>. The present inventors are unaware of any methods to make such material efficiently in high purity and relatively large scale production.</p><p id="p0003" num="0003"><nplcit id="ncit0001" npl-type="s"><text>Balenovic et al, Journal of Organic Chemistry, vol. 21, 1956, p115-118</text></nplcit> describes preparation of cyclic amino acetals from the corresponding amino acids, or from the well crystallized tetra-hydroimidazole derivatives of the phthalimidoaldehydes.</p><p id="p0004" num="0004"><nplcit id="ncit0002" npl-type="s"><text>Delogu et al, Journal of Organometallic Chemistry, vol. 268, 1984, p167-174</text></nplcit> describes hydrocarbonylation of some beta-unsaturated N-vinylphthalimides catalysed by Rh or Pd complexes.</p><p id="p0005" num="0005"><nplcit id="ncit0003" npl-type="s"><text>Gribble et al, Journal of Organic Chemistry, vol. 53, 1988, p3164-3170</text></nplcit> describes a biomimetic approach syntheses of (+/-)-elaeokanine A, (+/-)-elaeokanine C, (+/-)-elaeocarpidine, and (+/-)-tarennine.<!-- EPO <DP n="2"> --></p><heading id="h0003"><u>Summary of the Invention</u></heading><p id="p0006" num="0006">The method of the present invention provides an improved method for making amino dialkoxy compounds. This method comprises:
<ol><li>(a) providing an N-alkenylphthalimide;</li><li>(b) converting the alkenyl group to an aldehyde by hydroformylation;</li><li>(c) reacting the aldehyde with an alcohol or alkyl diol to form two alkoxy groups on or a cyclic diether with the carbon that was part of the aldehyde group - i.e. forming an acetal or cyclic acetal moiety; and</li><li>(d) then forming a primary amine by deprotection of the amine (i.e. removal of the phthalimide functionality);</li></ol>
wherein the hydroformylation step occurs in the presence of syngas and a catalyst which is a complex of rhodium with a bidentate phosphorous containing ligand.</p><heading id="h0004"><u>Detailed Description of the Invention</u></heading><p id="p0007" num="0007">Preferably, the alkenyl group of steps a and b is an alkenyl of up to 5 carbon atoms, more preferably 3 or 4 carbon atoms and most preferably 3 carbon atoms (i.e. an allyl group - also referred to as propenyl group).<!-- EPO <DP n="3"> --></p><p id="p0008" num="0008">The first step of providing the N-alkenylphthalimide may be undertaken by any known method. For example, one may react a potassium phthalimide (or analogous compound) with a alkenyl halide such as alkenyl chloride or alkenyl bromide; one may react an alkenyl amine with a phthalic anhydride; one may use preformed potassium phthalimide or form the potassium phthalimide in situ; or use these methods with or without a quaternary ammomiun salt as catalyst. See e.g. <nplcit id="ncit0004" npl-type="s"><text>Abulikemu, Abudurexiti; Halasz, Gabor; Csampai, Antal; Gomory, Agnes; Rabai, Jozsef, Improved synthesis of perfluorooctylpropyl amine, Journal of Fluorine Chemistry (2004), 125(7), 1143-1146</text></nplcit>, describing the synthesis of <i>N</i>-allyl phthalimide (75% yield) via the reaction of phthalic anhydride and allyl amine in acetic acid at reflux over two hours; <nplcit id="ncit0005" npl-type="s"><text>Koehling, Petra; Schmidt, Axel M.; Eilbracht, Peter, Tandem Hydroformylation/Fischer Indole Synthesis: A Novel and Convenient Approach to Indoles from Olefins, Organic Letters (2003), 5(18), 3213-3216</text></nplcit>, describing the reaction of potassium phthalimide with allyl bromide in dimethylformamide (DMF) over 24h to yield N-allyl phthalimide in 72% yield; <nplcit id="ncit0006" npl-type="s"><text>Pawar, N. S.; Attarde, S. B.; Dalal, D. S.; Sonar, G. R.; Kapadi, U. R.; Hundiwale, D. G.; Kumbhar, P. P, Synthesis of N-alkyl and N-acyl phthalimides using polymer-supported phthalimide anion, Journal of Indian Council of Chemists (2001), 18(2), 29-31</text></nplcit>, describing the reaction of phthalimide with allyl bromide in the presence of KOH and Amberlite IRA 400 to yield <i>N</i>-allyl phthalimide in 91% yield; <nplcit id="ncit0007" npl-type="s"><text>Daiss, Juergen O.; Duda-Johner, Seraina; Burschka, Christian; Holzgrabe, Ulrike; Mohr, Klaus; Tacke, Reinhold, N+/Si Replacement as a Tool for Probing the Pharmacophore of Allosteric Modulators of Muscarinic M2 Receptors: Synthesis, Allosteric Potency, and Positive Cooperativity of Silicon-Based W84 Derivatives, Organometallics (2002), 21(5), 803-811</text></nplcit>, reporting the reaction of potassium phthalimide with allyl chloride to give <i>N</i>-allyl phthalimide in 62% yield; <nplcit id="ncit0008" npl-type="s"><text>Heyes, James A.; Niculescu-Duvaz, Dan; Cooper, Robert G.; Springer, Caroline J. Synthesis of Novel Cationic Lipids: Effect of Structural Modification on the Efficiency of Gene Transfer, Journal of Medicinal Chemistry (2002), 45(1), 99-114</text></nplcit>, describing the reaction of potassium phthalimide with allyl bromide in DMF to yield N-allyl phthalimide in 80% yield; <nplcit id="ncit0009" npl-type="s"><text>Khatri, Dilip; Rajora, Sonal; Banu, Tahira; Talesara, G. L. Synthesis of bis-1,2-aryl-biguanidino-oxy, 3-biguanidinopropane as potential antimalarials, Asian Journal of Chemistry (1999), 11(4), 1438-1444</text></nplcit>, describing the reaction of potassium phthalimide with allyl bromide in the presence of tetrabutylammonium bromide in toluene to yield N-allyl phthalimide in 80% yield;<nplcit id="ncit0010" npl-type="s"><text> Vlassa, M.; Kezdi, Maria; Fenesan, Maria, Preparation of N-alkylphthalimides using solid-liquid phase transfer catalysis without solvent. Revue Roumaine de Chimie (1989),<!-- EPO <DP n="4"> --> 34(7), 1607-9</text></nplcit>, describing the reaction of potassium phthalimide with allyl bromide in the presence of tetrabutylammonium bromide to yield N-allyl phthalimide in 95% yield; and <nplcit id="ncit0011" npl-type="s"><text>Anelli, Pier Lucio; Montanari, Fernando; Pollak, Vladimir; Quici, Silvio. Synthesis of crown ethers bonded to a polystyrene matrix through an amido linkage and their use as phase-transfer catalysts, Gazzetta Chimica Italiana (1986), 116(3), 127-31</text></nplcit>, describing the reaction of potassium phthalimide with allyl bromide in the presence of phosphonium salt and toluene to yield N-allyl phthalimide in 92% yield.</p><p id="p0009" num="0009">According to a particularly preferred embodiment, a potassium phthalimide compound is reacted with an alkenyl chloride in an organic solvent at a temperature of at least room temperature but preferably no more than 100° C, more preferably no more than 60° C. The organic solvent is preferably an aprotic solvent, more preferably is selected from toluene, dimethylformamide (DMF), tetrahydrofuran (THF), acetonitrile, ethylacetate or tert-butylmethylether, and most preferably is DMF. The reactants are preferably present in approximately stoichiometric amounts to each other. An ammonium salt may be added, preferably a quaternary ammonium salt, in order to aid the reaction by increasing conversion and yields. The reactants are preferably present in concentrations of weight reactant to volume solvent percentage ratio (w/v%) between 50 w/v% and 5 w/v%, and more preferably between 50 w/v% and 25 w/v%. The reaction may be quenched by addition of water. The product may be precipitated preferably at reduced temperatures. The precipitate may be washed and recrystallized, for example from a lower alcohol such as ethanol to yield the N-alkenyl phthalimide. The yield of this first step is preferably at least 60%, more preferably 70% or more.</p><p id="p0010" num="0010">In the second step of the method the <i>N</i>-alkenyl phthalimide is hydroformylated to form an aldehyde. The hydroformylation step occurs in the presence of a hydroformylation catalyst and syn gas. The syn gas preferably comprises CO and H<sub>2</sub> in mole ratios of 0.1:1 to 1:0.1, more preferably in mole ratio of 0.9:1 to 1:0.9. Preferred catalysts are those that will provide regiospecificity for the resulting aldehydes (e.g. will provide more of the desired regiospecific aldehyde). Suitable catalysts for this purpose comprise rhodium (Rh) complexed to a bidentate phosphorus-containing ligand.<!-- EPO <DP n="5"> --></p><p id="p0011" num="0011">Preferably, the ligand is a bisphosphite represented by formula (<b>1</b>), wherein R<sup>1</sup> is tert-butyl, methoxy or 2,4,6-trimethylphenyl; R<sup>2</sup> is tert-butyl or trimethylsilyl; A is the structural fragment according to formula <b>I</b> in which R<sup>3</sup> is tert-butyl, methoxy or hydrogen and R<sup>4</sup> is tert-butyl, trimethylsilyl or hydrogen; B is the same as A when R<sup>3</sup> and R<sup>4</sup> are both hydrogen or, when R<sup>3</sup> and R<sup>4</sup> are not both hydrogen, a structural fragment according to formulae <b>II</b> or <b>III</b>, in which R<sup>5</sup> through R<sup>8</sup> are alkyl, halogen, methoxy or hydrogen.. Representative ligands of this type, having utility in the process of the invention, are selected from the group including BIPHEPHOS (<b>2</b>), (<b>3</b>) and the unsymmetrical bisphosphite (<b>4</b>) in which R is H, CH<sub>3</sub>, OCH<sub>3</sub>, or OC<sub>2</sub>H<sub>5</sub>. A rhodium complex of BIPHEPHOS (<b>2</b>) is a particularly preferred catalyst.
<chemistry id="chem0001" num="0001"><img id="ib0001" file="imgb0001.tif" wi="62" he="27" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0002" num="0002"><img id="ib0002" file="imgb0002.tif" wi="61" he="22" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0003" num="0003"><img id="ib0003" file="imgb0003.tif" wi="110" he="30" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0004" num="0004"><img id="ib0004" file="imgb0004.tif" wi="56" he="31" img-content="chem" img-format="tif"/></chemistry></p><p id="p0012" num="0012">For operation of the process of the invention, a pre-formed, storage-stable complex of the transition metal and phosphorus-containing ligand may be employed, although more commonly, the catalyst complex is prepared in solution prior to use, and said solution is combined in the reaction vessel with a solution of the alkenyl substrate and syngas.<!-- EPO <DP n="6"> --> Preparation of the solution of catalyst complex entails reaction of the ligand with a precursor complex containing the transition metal, optionally using a molar excess of ligand such that uncomplexed ligand is present once the entire precursor complex is consumed. Preferably the molar ratio of ligand:transition metal is in the range of about 0.75:1 to 100:1, and more preferably this ratio is in the range of about 0.75:1 to 3:1. Where the transition metal is Rh, the precursor complex is preferably a Rh(I) or Rh(III) complex, more preferably selected from Rh<sub>6</sub>(CO)<sub>16</sub>, Rh<sub>4</sub>(CO)<sub>12</sub>, [Rh(COD)<sub>2</sub>]BF<sub>4</sub>, [RhCl(COD)]<sub>2</sub>, [RhCl(COE)<sub>2</sub>]<sub>2</sub>, Rh<sub>2</sub>(acetate)<sub>4</sub>, Rh(acac)<sub>3</sub>, RhCl<sub>3</sub> and Rh(COD)(acac), and most preferably is Rh(acac)(CO)<sub>2</sub>. In the aforementioned complexes the following abbreviations apply: COD= 1,5-cyclooctadiene, COE = cyclooctene, acac = acetylacetonato.</p><p id="p0013" num="0013">Preferably this reaction occurs at a temperature of at least room temperature, more preferably at least 60 ° C and a temperature of no greater than 150 ° C, more preferably no greater than 100 ° C. The pressure of the reaction is preferably maintained in the range of 10 to 250, more preferably 20-60, pounds per square inch (psi) gauge pressure. The reaction preferably occurs in a suitable organic solvent such as toluene, tetrahydrofuran, or other solvents that are characterized as being aprotic. The concentration of the N-alkenyl phthalimide is preferably between 50 w/v% and 5 w/v%, and more preferably between 50 w/v% and 20 w/v%. The mole ratio of the N-alkenyl phthalimide to catalyst is preferably at least 1000:1, more preferably at least 2500:1.</p><p id="p0014" num="0014">For the preferred alkenyl group which is allyl, the hydroformylation reaction preferably yields a molar ratio of linear to branched aldehyde of at least 2:1, more preferably at least 5:1, and even more preferably at least 10:1. The yield of the hydroformylation step is preferably at least 90%, more preferably at least 95%.</p><p id="p0015" num="0015">The hydroformylation of <i>N</i>-acylamino olefins to yield <i>N</i>-acyl amino aldehydes, in particular the use of N-phthalimido allylamine and N-diacetyl allyl amine has been reported (see<nplcit id="ncit0012" npl-type="b"><text> N-Acylamino aldehydes Ajinomoto Co. Inc., (1963</text></nplcit>), <patcit id="pcit0002" dnum="FR1341874"><text>FR 1341874 </text></patcit>19631102). The catalysts employed were non-ligand modified Rh or Co carbonyl complexes and as a result, the conditions reported were harsh (30 - 150°C, 710 to 14,210 psi, with CO:H<sub>2</sub> ratio being between 1:0.5 and 1:10). The examples given were run at 120°C and 2,349 psi, yielding the corresponding aldehydes in 78% yield and with a linear to branched product ratio of 7:3.</p><p id="p0016" num="0016">Hydroformylation of the <i>N</i>-allyl phthalimide in the presence of a hydrazone has been reported (see, <i>2,3-Disubstituted indoles from olefins and hydrazines via tandem<!-- EPO <DP n="7"> --> hydroformylation-Fischer indole synthesis and skeletal rearrangement.</i> <nplcit id="ncit0013" npl-type="s"><text>P. Linnepe, A.M. Schmidt and P. Eilbracht, Organic &amp; Biomolecular Chemistry (2006), 4, 302-313</text></nplcit>. This resulted in a mixture of regioisomers that spontaneously formed the corresponding indoles <i>in situ.</i> A Rh-Xantphos system together with a Syngas ratio of 5:2 (CO:H<sub>2</sub>) was employed, but linear to branched product ratio for the reaction was not stated.</p><p id="p0017" num="0017">In step (c), the aldehydes from step (b) may be directly converted to the acetals without purification or separation of the regioisomers. This reaction may occur via any known method of forming acetal from aldehydes, but preferably comprises contacting the aldehyde with an alcohol or diol to form acetal or cyclic acetal functionality. This reaction is preferably run by addition of the alcohol or diol and an acid catalyst according to known methods (for a review see, "<nplcit id="ncit0014" npl-type="b"><text>Protective Groups in Organic Synthesis", Eds T.W. Greene and P.G.M. Wuts, John Wiley &amp; Sons, Inc., 1991, 178-198</text></nplcit>). The alcohol may be any alcohol but is preferably a lower alcohol of up to 7 carbon atoms, preferably up to 2 carbon atoms and most preferably is methanol. A diol of 2 to 5 carbon atoms, preferably up to 2 carbon atoms may be used to provide a cyclic acetal group is desired. The amount of acid catalyst used is preferably less than 5 mol% and more preferably less than 1 mol%. This reaction is preferably run at a temperature of at least room temperature, but preferably no more than 70 ° C, more preferably no more than 40 ° C. An excess of the alcohol relative to the total amount of aldehydes may be used and in some cases may constitute the bulk reaction solvent. Yield of acetals is preferably at least 80%, more preferably at least 90%, with a ratio of linear to branched acetals of at least 2:1, more preferably at least 5:1, and even more preferably at least 10:1.</p><p id="p0018" num="0018">In step (d), the acetal compounds from step (c) are then reacted to remove the phthalimide group. This reaction may occur by use of known deprotecting agents according to standard methods as described in the literature (for a review see, "<nplcit id="ncit0015" npl-type="b"><text>Protective Groups in Organic Synthesis", Eds T.W. Greene and P.G.M. Wuts, John Wiley &amp; Sons, Inc., 1991, 358-359</text></nplcit>). MeNH<sub>2</sub> is a preferred deprotecting agent, because the resulting phthalimide adduct may be easily removed by filtration or extraction in an aqueous basic solution. Alternatively, deprotection could occur via use of hydrazine, a strong base, or a less soluble amine that would enable more effective precipitation of the phthalimido amine by-product. The preferred deprotection occurs in an alcohol solvent and MeNH<sub>2</sub> at concentrations of 2 to 10 Molar, preferably 2 to 8 Molar. The concentration of the phthalimide acetal concentration is preferably between 150 w/v% and 10 w/v%, and more preferably between 100 w/v% and 20 w/v%. The deprotection occurs at room temperature or higher, but preferably at a<!-- EPO <DP n="8"> --> temperature less than 70° C, more preferably less than 40° C. Yield at this step is preferably at least 80%, more preferably at least 90%.</p><p id="p0019" num="0019">Preferably the mixture of alkoxy amine compounds is distilled to obtain the desired regioisomer. In a preferred embodiment of the invention, to obtain 4-aminobutyraldehyde dimethyl acetal, the temperature for the distillation is preferably 100 to 150° C at a pressure of 15 to 50 millibar.</p><p id="p0020" num="0020">Thus, according to a preferred embodiment, the reaction proceeds according to the following scheme:
<chemistry id="chem0005" num="0005"><img id="ib0005" file="imgb0005.tif" wi="165" he="92" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0005"><u>Examples</u></heading><heading id="h0006"><b><i>Step (a): N-vinyl phthalimide formation</i></b></heading><heading id="h0007"><b><i>Lab-scale:</i></b></heading><p id="p0021" num="0021"><chemistry id="chem0006" num="0006"><img id="ib0006" file="imgb0006.tif" wi="131" he="28" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="9"> --></p><p id="p0022" num="0022">Potassium phthalimide (40.0 g, 0.216 mol) and tetrabutylammonium bromide (1.0 g, 6.204 mmol) were suspended in anhydrous DMF (150 ml). Allyl chloride (17.6 ml, 0.216 mol) was added dropwise over 10 min and the reaction allowed to stir at room temperature for 18 h. The reaction was then quenched with H<sub>2</sub>O (200 ml) and the resulting suspension stirred for 10 min (an ice bath was applied during this time to aid precipitation). The resulting precipitate was filtered off, washed with H<sub>2</sub>O and dried in air over a slight vacuum for 2 h. The resulting off-white solid was shown by <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy to be the desired compound (32.8 g, 81.0% yield). This crude material (76.3 g) was subsequently recrystallised from ethanol (270 ml) to yield the desired compound as a pure white solid (67.44g, 88.4% recovery).</p><p id="p0023" num="0023"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 4.30 (2H, CH<sub>2</sub>, d, <i>J</i><sup>3</sup> 5.7 Hz), 5.20 (1H, C<i>H</i>H=CH, dd, <i>J</i><sup>3</sup> 10.0 Hz, <i>J</i><sup>2</sup> 1.1 Hz), 5.25 (1H, C<i>H</i>H=CH, dd, <i>J</i><sup>3</sup> 16.9 Hz, <i>J</i><sup>2</sup> 1.1 Hz), 5.89 (1H, CHH=C<i>H</i>, m), 7.73 (2H, Ar, m), 7.86 (2H, Ar, m).<br/>
<sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, 100 MHz): δ 40.4, 118.1, 123.7, 131.9, 132.5, 134.4, 168.3.</p><heading id="h0008"><i>Larger scale preparation:</i></heading><p id="p0024" num="0024"><tables id="tabl0001" num="0001"><table frame="none"><tgroup cols="3" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="21mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="56mm"/><tbody><row><entry>Quantities :</entry><entry>950 g</entry><entry>potassium phthalimide</entry></row><row><entry/><entry>3.561</entry><entry>dimethylformamide</entry></row><row><entry/><entry>23.8 g</entry><entry>tetrabutylammonium bromide (TBAB)</entry></row><row><entry/><entry>391.9 g</entry><entry>allyl chloride</entry></row><row><entry/><entry>4.751</entry><entry>water</entry></row><row><entry/><entry>3.01</entry><entry>water wash</entry></row></tbody></tgroup></table></tables></p><p id="p0025" num="0025">Potassium phthalimide and TBAB were charged to a 10 1 glass jacketed reactor, DMF was added and the mixture slurried at 15-20 °C. Allyl chloride was ran in over 20 minutes giving no apparent exotherm, then the mixture was stirred overnight at ambient temperature to give a mobile slurry.</p><p id="p0026" num="0026">Water was added to the reaction mixture over 1 hour giving a slight exotherm and a white slurry, the temperature was maintained below 32 °C using 10 °C glycol in the reactor jacket. The mixture was filtered on a Buchner funnel under vacuum and washed thoroughly with<!-- EPO <DP n="10"> --> water to give 1154.3 g of damp product. This was dried overnight at 45 °C in vacuo giving 771.0 g white solid product.</p><heading id="h0009"><b><i>Step (b): Hydroformylation of N-allylphthalimide:</i></b></heading><heading id="h0010"><b><i>Lab-scale:</i></b></heading><p id="p0027" num="0027"><chemistry id="chem0007" num="0007"><img id="ib0007" file="imgb0007.tif" wi="99" he="47" img-content="chem" img-format="tif"/></chemistry></p><p id="p0028" num="0028">The reaction was performed in a 600 ml Parr pressure vessel fitted with a glass liner, double impeller, injection port, bursting disk, pressure relief valve and pressure gauge. The glass liner was charged with Rh(CO)<sub>2</sub>(acac) (18.4 mg, 0.07 mmol) and BIPHEPHOS (58.8 mg, 0.075 mmol), the vessel sealed and flushed five times with nitrogen (145 psi). THF (40 ml, anhydrous and deoxygenated) was added to the vessel via the injection port and the system flushed three times with Syn gas (145 psi, 1:1). The vessel was heated to 40 °C, charged to 80 psi with Syn gas (1:1) and stirred (1,000 rpm) for 20 mins. After this time, the stirring was stopped and the pressure released. A THF solution (200 ml) of N-allyl phthalimide (40.0 g, 0.214 mol) was then added via syringe and the vessel flushed a further three times with Syn gas (145 psi, 1:1). The reaction was heated to 80 °C and charged to 40 psi with Syn gas (1:1). The pressure was monitored and maintained at this pressure for 4 h, consumption was seen to stop within 3 h. The stirring was reduced to 500 rpm and the vessel allowed to cool to room temperature, vented to atmosphere, flushed once with nitrogen (145 psi) and opened. An aliquot of the reaction mixture was analysed by LC and <sup>1</sup>H NMR spectroscopy. This showed the reaction had gone to completion with an n:iso ratio of 11.5. The reaction mixture was reduced to dryness to yield a crude cream coloured solid (48.2 g, 103.9%).</p><heading id="h0011"><i>Linear aldehyde</i></heading><p id="p0029" num="0029"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 2.02 (2H, CH<sub>2</sub>, m), 2.55 (2H, C<i>H</i><sub>2</sub>CHO, t, <i>J</i><sup>3</sup> 7.4 Hz), 3.74 (2H, C<i>H</i><sub>2</sub>N, t, <i>J</i><sup>3</sup> 6.9 Hz), 7.73 (2H, Ar, m), 7.85 (2H, Ar, m), 9.78 (1H, CHO, s).<br/>
<!-- EPO <DP n="11"> --><sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, 100 MHz): δ 21.6, 37.5, 41.5, 123.7, 132.4, 134.4, 168.8, 201.3.</p><heading id="h0012"><i>Branched aldehyde</i></heading><p id="p0030" num="0030"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 1.18 (3H, CH<sub>3</sub>, d, <i>J</i><sup>3</sup> 7.0 Hz), 2.90 (1H, C<i>H</i>CHO, m), 3.82 (1H, C<i>H</i>HN, dd, <i>J</i><sup>3</sup> 6.6 Hz, <i>J</i><sup>2</sup> 14.1 Hz), 4.04 (1H, C<i>H</i>HN, dd, <i>J</i><sup>3</sup> 7.0 Hz, <i>J</i><sup>2</sup> 14.1 Hz), 7.74 (2H, Ar, m), 7.85 (2H, Ar, m), 9.77 (1H, CHO, d, <i>J</i><sup>3</sup> 1.9 Hz).<br/>
<sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, 100 MHz): δ 12.0, 38.5, 46.2, 123.8, 132.2, 134.5, 168.6, 202.6.</p><p id="p0031" num="0031">LC conditions: Kromasil C<sub>18</sub> column, 250x4.6 mm x 5 µm, MeCN/H<sub>2</sub>O (45 :55), 230nm, 11 min (N-allyl amine), 7 min (linear aldehyde), 8 min (branched aldehyde).</p><heading id="h0013"><b><i>Larger scale preparation:</i></b></heading><p id="p0032" num="0032"><tables id="tabl0002" num="0002"><table frame="none"><tgroup cols="3" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="31mm"/><colspec colnum="2" colname="col2" colwidth="18mm"/><colspec colnum="3" colname="col3" colwidth="30mm"/><tbody><row><entry>Typical quantities :</entry><entry>200g</entry><entry><i>N</i>-allyl phthalimide</entry></row><row><entry/><entry>1.01</entry><entry>toluene</entry></row><row><entry/><entry>91.9 mg</entry><entry>Rh(CO)<sub>2</sub>(acac)</entry></row><row><entry/><entry>308.2 mg</entry><entry>BIPHEPHOS</entry></row><row><entry/><entry>10 mls</entry><entry>toluene</entry></row><row><entry/><entry>qs</entry><entry>Syn-gas 50/50</entry></row></tbody></tgroup></table></tables></p><p id="p0033" num="0033"><i>N</i>-allyl phthalimide was charged to a glass liner of a 2 1 Parr vessel, toluene was added and the vessel assembled. This was purged 5 times by pressurising to 6 bar with nitrogen and venting, then purged once with Syn-gas to 40 psi and vented.</p><p id="p0034" num="0034">Rh(CO)<sub>2</sub>(acac) and BIPHEPHOS charged to a glass liner of a 50 ml Parr vessel and the vessel was assembled. This was purged 6 times by pressurising to 4 bar with Syn-gas and venting, degassed toluene was then added through a septum and the vessel charged to 50 psi with Syn-gas. This was then heated to 45 °C for 45 minutes with rapid stirring, then the activated catalyst solution removed into a syringe and transferred to the 21 Parr vessel.</p><p id="p0035" num="0035">The 2 1 Parr vessel was then charged to 40 psi with Syn-gas and heated to 80 °C, maintaining the desired pressure with constant addition of Syn-gas until gas uptake ceased. The vessel was cooled to 20 °C, purged with nitrogen and sampled. This showed the reaction to be complete (&lt; 1% starting material). The solution was then concentrated on a<!-- EPO <DP n="12"> --> rotary evaporator at 45 °C to give approximately 250g of off-white solid product containing some residual toluene.</p><p id="p0036" num="0036">The above procedure was carried out four times using 3 x 200g and 1 x 150g starting material, yielding 942.6g of crude product with an estimated active content of 870g.</p><heading id="h0014"><b><i>Step (c): Acetal formation</i></b></heading><p id="p0037" num="0037"><chemistry id="chem0008" num="0008"><img id="ib0008" file="imgb0008.tif" wi="106" he="49" img-content="chem" img-format="tif"/></chemistry></p><p id="p0038" num="0038">The crude mixture of phthalimido aldehydes produced as detailed above (0.214 mol) was dissolved in MeOH (150 ml) and conc. H<sub>2</sub>SO<sub>4</sub> (0.092 g) was added. The reaction was stirred overnight and then neutralized with 4.0M NaOH. All volatiles were removed in vacuo to yield a crude orange oil, which LC and <sup>1</sup>H NMR showed to be the desired dimethyl acetal as a mixture of regioisomers (53.8 g, 95.5% yield, n:iso 12.7).</p><heading id="h0015"><i>Linear dimethylacetal</i></heading><p id="p0039" num="0039"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 1.66 (2H, CH<sub>2</sub>, m), 1.75 (2H, CH<sub>2</sub>, m), 3.31 (6H, CH<sub>3</sub>, s), 3.74 (2H, C<i>H</i><sub>2</sub>N, t, <i>J</i><sup>3</sup> 7.2 Hz), 4.40 (1H, C<i>H</i>(OCH<sub>3</sub>)<sub>2</sub>, t, <i>J</i><sup>3</sup> 5.5 Hz), 7.71 (2H, Ar, m), 7.84 (2H, Ar, m).<br/>
<sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, 100 MHz): δ 24.2, 30.2, 38.0, 53.2, 104.4, 123.5, 132.4, 134.2, 168.7.</p><p id="p0040" num="0040">LC conditions: Kromasil C<sub>18</sub> column, 250x4.6 mm x 5 µm, MeCN/H<sub>2</sub>O (45 :55), 230nm, 7 min (linear aldehyde), 10 min (linear acetal).<!-- EPO <DP n="13"> --></p><heading id="h0016"><b><i>Steps (c) &amp; (d) combined: Acetal formation and phthalimide removal</i></b></heading><heading id="h0017"><b><i>Lab-scale:</i></b></heading><p id="p0041" num="0041"><chemistry id="chem0009" num="0009"><img id="ib0009" file="imgb0009.tif" wi="133" he="45" img-content="chem" img-format="tif"/></chemistry></p><p id="p0042" num="0042">The crude mixture of phthalimido aldehydes (12.57 g, 0.058 mol) produced as detailed above (n:iso 11.3) was suspended in MeOH (12.7 ml) and conc. H<sub>2</sub>SO<sub>4</sub> (0.1 ml) was added, resulting in instant dissolution of all solids The reaction was stirred for 1 h and then an aqueous solution of MeNH<sub>2</sub> (40% w/w, 44.9 g 0.58 mol)was added. The reaction was stirred at room temperature overnight during which time a fine white precipitate formed. 5.0 M NaOH(<sub>aq</sub>) solution (12.73 ml) was added to the main reaction mixture, dissolving the solid, and stirred at room temperature for 2 h. This phase was then extracted twice with MTBE (1 x 20 ml and 1 x 40 ml) and the organic phases separated and combined. Upon removal of all volatiles in vacuo, the residual oil was found to represent only 26% of the expected mass recovery. NaCl (5 g) was added to the aqueous phase, which was then extracted with dichloromethane (40 ml). Removal of all volatiles yielded a clear colourless oil that represented 70% of the expected mass recovery. GC, <sup>1</sup>H and <sup>13</sup>C NMR showed the combined oils to be a mixture of regioisomers of the free aminobutyraldehyde dimethyl acetals (n:iso 28.4) together with small amounts of H<sub>2</sub>O, MeOH and toluene (7.41 g, 96%).</p><heading id="h0018"><i>4-Aminobutyraldehyde dimethyl acetal</i></heading><p id="p0043" num="0043"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 1.51 (2H, CH<sub>2</sub>, m), 1.63 (2H, CH<sub>2</sub>, m), 1.9 (2H, NH<sub>2</sub>, bs), 2.71 (2H, C<i>H</i><sub>2</sub>N, t, <i>J</i><sup>3</sup> 7.1 Hz), 3.33 (6H, CH<sub>3</sub>, s), 4.38 (1H, C<i>H</i>(OCH<sub>3</sub>)<sub>2</sub>, t, <i>J</i><sup>3</sup> 5.5 Hz).<br/>
<sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, 100 MHz): δ 28.9, 30.2, 42.1, 53.1, 104.8.<!-- EPO <DP n="14"> --></p><heading id="h0019"><i>3-Amino-2-methylproprylaldehyde dimethyl acetal</i></heading><p id="p0044" num="0044"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz); δ 0.94 (3H, CH<sub>3</sub>, d, <sup>3</sup><i>J</i> 6.6 Hz), 1.16 (1H, NH<sub>2</sub>, bs), 1.83 (1H, CH, m), 2.57 (1H, C<i>H</i><sub>2</sub>N, m), 2.79 (1H, C<i>H</i><sub>2</sub>N, m), 3.36 (3H, CH<sub>3</sub>, s), 3.38 (3H, CH<sub>3</sub>, s), 4.15 (1H, C<i>H</i>(OCH<sub>3</sub>)<sub>2</sub>, d, <sup>3</sup><i>J</i> 6.6 Hz).<br/>
<sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, 100 MHz): δ 13.4, 37.0, 39.1, 53.9, 54.9, 108.4.</p><p id="p0045" num="0045">GC Conditions: ZB5 column, 30 m x 0.32 mm x 1.0 µm, MeCN for sample preparation, 160 °C for 6 min, 4 min (branched dimethyl acetal), 5 min (linear dimethyl acetal).</p><heading id="h0020"><b><i>Larger scale preparation:</i></b></heading><p id="p0046" num="0046"><tables id="tabl0003" num="0003"><table frame="none"><tgroup cols="3" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="20mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="65mm"/><tbody><row><entry>Quantities:</entry><entry>906.7 g</entry><entry>Stage 2 crude product (estimated 825g pure)</entry></row><row><entry/><entry>660 g</entry><entry>methanol</entry></row><row><entry/><entry>0.5 g</entry><entry>sulphuric acid 98%</entry></row><row><entry/><entry>2.95 kg</entry><entry>methylamine 40% w/w aqueous</entry></row><row><entry/><entry>522 g</entry><entry>sodium hydroxide 32%</entry></row><row><entry/><entry>400 g</entry><entry>sodium chloride</entry></row><row><entry/><entry>3.251</entry><entry>dichloromethane (DCM)</entry></row></tbody></tgroup></table></tables></p><p id="p0047" num="0047">The crude concentrated hydroformylation product was charged to a 3 1 flask with methanol, sulphuric acid added and the reaction stirred at ambient temperature to give a clear pale yellow solution. This was then transferred to a 10 1 glass jacketed reactor and methylamine solution added, giving an instant exotherm to 35 °C. The reaction was cooled to ambient temperature and stirred for 24 hours, with a thick white precipitate forming after approximately 2 hours.</p><p id="p0048" num="0048">Sodium hydroxide solution was ran in over 1 hour to give a cloudy solution, which was stirred for 2 hours at ambient temperature. Sodium chloride was added and the reaction stirred to aid dissolution, then multiple phase separations were carried out using a total of 3.25 litres of dichloromethane in quantities between 0.25 1 and 0.75 1. Combined DCM extracts were then concentrated on a rotary evaporator to give 345.0 g of product as a pale yellow liquid.<!-- EPO <DP n="15"> --></p><heading id="h0021"><b><i>Step (e): Fractional distillation</i></b></heading><p id="p0049" num="0049"><chemistry id="chem0010" num="0010"><img id="ib0010" file="imgb0010.tif" wi="95" he="35" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0022"><b><i>Process development scale:</i></b></heading><p id="p0050" num="0050">340 g of crude aminobutyraldehyde dimethyl acetal from the larger scale preparation was distilled in a 1 litre glass flask fitted with nitrogen bleed, 300 mm x 30 mm diameter stainless steel mesh fractionation column and reflux ratio head. The following fractions were collected:
<tables id="tabl0004" num="0004"><img id="ib0011" file="imgb0011.tif" wi="157" he="64" img-content="table" img-format="tif"/></tables><!-- EPO <DP n="16"> --></p><p id="p0051" num="0051">Analysis of these fractions by <sup>1</sup>H NMR and GC showed them to contain the following constituents:
<tables id="tabl0005" num="0005"><img id="ib0012" file="imgb0012.tif" wi="93" he="65" img-content="table" img-format="tif"/></tables></p><heading id="h0023"><i>4-Aminobutyraldehyde dimethyl acetal</i></heading><p id="p0052" num="0052"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 1.51 (2H, CH<sub>2</sub>, m), 1.63 (2H, CH<sub>2</sub>, m), 1.9 (2H, NH<sub>2</sub>, bs), 2.71 (2H, C<i>H</i><sub>2</sub>N, t, <i>J</i><sup>3</sup> 7.1 Hz), 3.33 (6H, CH<sub>3</sub>, s), 4.38 (1H, C<i>H</i>(OCH<sub>3</sub>)<sub>2</sub>, t, <i>J</i><sup>3</sup> 5.5 Hz).<br/>
<sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, 100 MHz): δ 28.9, 30.2, 42.1, 53.1, 104.8.</p><heading id="h0024"><i>3-Amino-2-methylproprylaldehyde dimethyl acetal</i></heading><p id="p0053" num="0053"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz); δ 0.94 (3H, CH<sub>3</sub>, d, <sup>3</sup><i>J</i> 6.6 Hz), 1.16 (1H, NH<sub>2</sub>, bs), 1.83 (1H, CH, m), 2.57 (1H, C<i>H</i><sub>2</sub>N, m), 2.79 (1H, C<i>H</i><sub>2</sub>N, m), 3.36 (3H, CH<sub>3</sub>, s), 3.38 (3H, CH<sub>3</sub>, s), 4.15 (1H, C<i>H</i>(OCH<sub>3</sub>)<sub>2</sub>, d, <sup>3</sup><i>J</i> 6.6 Hz).<br/>
<sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, 100 MHz): δ 13.4, 37.0, 39.1, 53.9, 54.9, 108.4.</p><p id="p0054" num="0054">GC Conditions: ZB5 column, 30 m x 0.32 mm x 1.0 µm, MeCN for sample preparation, 160 °C for 6 min, 4 min (branched dimethyl acetal), 5 min (linear dimethyl acetal).</p></description><claims mxw-id="PCLM56984609" lang="DE" load-source="patent-office"><!-- EPO <DP n="19"> --><claim id="c-de-01-0001" num="0001"><claim-text>Verfahren, das Folgendes umfasst:
<claim-text>(a) Bereitstellen eines N-Alkenylphthalimids;</claim-text>
<claim-text>(b) Umwandeln der Alkenylgruppe zu einer Aldehydfunktionalität durch Hydroformylierung;</claim-text>
<claim-text>(c) Umsetzen des Aldehyds mit einem Alkohol oder Alkyldiol zur Bildung einer Acetal- oder einer zyklischen Acetal-Funktionalität; und</claim-text>
<claim-text>(d) anschließende Bildung eines primären Amins durch Entschützung des Amins,<br/>
wobei der Hydroformylierungsschritt in Gegenwart von Synthesegas und einem Katalysator erfolgt, der aus einem Komplex von Rhodium mit einem Phosphor enthaltenden Bidentatliganden besteht.</claim-text></claim-text></claim><claim id="c-de-01-0002" num="0002"><claim-text>Verfahren nach Anspruch 1, das ferner eine fraktionierte Destillation nach der Bildung des primären Amins umfasst.</claim-text></claim><claim id="c-de-01-0003" num="0003"><claim-text>Verfahren nach Anspruch 1 oder 2, wobei das N-Alkenylphthalimid ein <i>N</i>-Allylphthalimid ist.</claim-text></claim><claim id="c-de-01-0004" num="0004"><claim-text>Verfahren nach einem der Ansprüche 1-3, wobei der Schritt des Bereitstellens eines <i>N</i>-Alkenylphthalimids das Umsetzen von Kaliumphthalimid mit einem Allylhalogenid umfasst.</claim-text></claim><claim id="c-de-01-0005" num="0005"><claim-text>Verfahren nach Anspruch 4, wobei das Allylhalogenid Allylchlorid oder Allylbromid ist.</claim-text></claim><claim id="c-de-01-0006" num="0006"><claim-text>Verfahren nach einem der Ansprüche 1-5, wobei die sich<!-- EPO <DP n="20"> --> aus dem Hydroformylierungsschritt ergebenden Aldehyd-Regioisomere in einem Verhältnis von geradkettig zu verzweigtkettig von mindestens 2:1 vorhanden sind.</claim-text></claim><claim id="c-de-01-0007" num="0007"><claim-text>Verfahren nach Anspruch 6, wobei das molare Verhältnis von geradkettigem zu verzweigtkettigem Aldehyd mindestens 10:1 beträgt und die Alkenylgruppe Allyl ist.</claim-text></claim><claim id="c-de-01-0008" num="0008"><claim-text>Verfahren nach einem der Ansprüche 6 bis 7, wobei der Ligand:
<chemistry id="chem0012" num="0012"><img id="ib0014" file="imgb0014.tif" wi="81" he="43" img-content="chem" img-format="tif"/></chemistry>
ist.</claim-text></claim><claim id="c-de-01-0009" num="0009"><claim-text>Verfahren nach einem der Ansprüche 1-8, wobei der Alkohol in Schritt (c) Methanol oder Ethanol ist.</claim-text></claim><claim id="c-de-01-0010" num="0010"><claim-text>Verfahren nach Anspruch 9, wobei der Alkohol Methanol ist.</claim-text></claim><claim id="c-de-01-0011" num="0011"><claim-text>Verfahren nach einem der Ansprüche 1-10, wobei die Entschützung über die Addition eines Entschützungsreagenzes geschieht, das ausgewählt ist aus einer wässrigen Base, einem Amin oder einem Hydrazin.</claim-text></claim><claim id="c-de-01-0012" num="0012"><claim-text>Verfahren nach Anspruch 11, wobei das Entschützungsreagenz Methylamin ist.</claim-text></claim></claims><claims mxw-id="PCLM56984610" lang="EN" load-source="patent-office"><!-- EPO <DP n="17"> --><claim id="c-en-01-0001" num="0001"><claim-text>A method comprising
<claim-text>(a) providing an <i>N</i>-alkenylphthalimide;</claim-text>
<claim-text>(b) converting the alkenyl group to aldehyde functionality by hydroformylation;</claim-text>
<claim-text>(c) reacting the aldehyde with an alcohol or alkyl diol to form acetal or cyclic acetal functionality; and</claim-text>
<claim-text>(d) then forming a primary amine by deprotection of the amine.<br/>
wherein the hydroformylation step occurs in the presence of syngas and a catalyst which is a complex of rhodium with a bidentate phosphorous containing ligand.</claim-text></claim-text></claim><claim id="c-en-01-0002" num="0002"><claim-text>The method of claim 1 further comprising fractional distillation after formation of the primary amine.</claim-text></claim><claim id="c-en-01-0003" num="0003"><claim-text>The method of claim 1 or 2 wherein the <i>N</i>-alkenylphthalimide is <i>N</i>-allylphthalimide.</claim-text></claim><claim id="c-en-01-0004" num="0004"><claim-text>The method of any one of claims 1-3 wherein the step of providing an N-alkenylphthalimide comprises reacting potassium phthalimide with an allyl halide.</claim-text></claim><claim id="c-en-01-0005" num="0005"><claim-text>The method of claim 4 wherein the allyl halide is allyl chloride or allyl bromide.</claim-text></claim><claim id="c-en-01-0006" num="0006"><claim-text>The method of any one of claims 1-5 wherein the resulting aldehyde regioisomers from the hydroformylation step are present in ratios of linear to branched of at least 2:1.</claim-text></claim><claim id="c-en-01-0007" num="0007"><claim-text>The method of claim 6 wherein the molar ratio of linear to branched aldehyde is at least 10:1, and wherein the alkenyl group is allyl.</claim-text></claim><claim id="c-en-01-0008" num="0008"><claim-text>The method of any one of claims 6 to 7 wherein the ligand is:<!-- EPO <DP n="18"> -->
<chemistry id="chem0011" num="0011"><img id="ib0013" file="imgb0013.tif" wi="98" he="55" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-en-01-0009" num="0009"><claim-text>The method of any one of claims 1-8 wherein the alcohol in step (c) is methanol or ethanol.</claim-text></claim><claim id="c-en-01-0010" num="0010"><claim-text>A method of claim 9 wherein the alcohol is methanol.</claim-text></claim><claim id="c-en-01-0011" num="0011"><claim-text>The method of any one of claims 1-10 wherein the deprotection occurs via addition of a deprotecting reagent selected from an aqueous base, an amine or hydrazine,</claim-text></claim><claim id="c-en-01-0012" num="0012"><claim-text>A method of claim 11 wherein the deprotecting reagent is methylamine.</claim-text></claim></claims><claims mxw-id="PCLM56984611" lang="FR" load-source="patent-office"><!-- EPO <DP n="21"> --><claim id="c-fr-01-0001" num="0001"><claim-text>Procédé comprenant
<claim-text>(a) la fourniture d'un <i>N</i>-alcénylphtalimide ;</claim-text>
<claim-text>(b) la conversion du groupe alcényle en fonctionnalité aldéhyde par hydroformylation ;</claim-text>
<claim-text>(c) la réaction de l'aldéhyde avec un alcool ou un alkyldiol pour former une fonctionnalité acétal ou acétal cyclique ; et</claim-text>
<claim-text>(d) la formation ultérieure d'une amine primaire par déprotection de l'amine,<br/>
dans lequel l'étape d'hydroformylation est réalisée en présence d'un gaz de synthèse et d'un catalyseur qui est un complexe de rhodium avec un ligand contenant un phosphore bidenté.</claim-text></claim-text></claim><claim id="c-fr-01-0002" num="0002"><claim-text>Procédé selon la revendication 1, comprenant en outre une distillation fractionnelle après la formation de l'amine primaire.</claim-text></claim><claim id="c-fr-01-0003" num="0003"><claim-text>Procédé selon la revendication 1 ou 2, dans lequel le N-alcénylphtalimide est le N-allylphtalimide.</claim-text></claim><claim id="c-fr-01-0004" num="0004"><claim-text>Procédé selon l'une quelconque des revendications 1 à 3, dans lequel l'étape de fourniture d'un <i>N-</i>alcénylphtalimide comprend la réaction de phtalimide de potassium avec un halogénure d'allyle.</claim-text></claim><claim id="c-fr-01-0005" num="0005"><claim-text>Procédé selon la revendication 4, dans lequel l'halogénure d'allyle est un chlorure d'allyle ou un bromure d'allyle.<!-- EPO <DP n="22"> --></claim-text></claim><claim id="c-fr-01-0006" num="0006"><claim-text>Procédé selon l'une quelconque des revendications 1 à 5, dans lequel les régioisomères aldéhydiques résultant de l'étape hydroformylation sont présents dans des rapports de l'aldéhyde linéaire à l'aldéhyde ramifié d'au moins 2:1.</claim-text></claim><claim id="c-fr-01-0007" num="0007"><claim-text>Procédé selon la revendication 6, dans lequel le rapport molaire de l'aldéhyde linéaire à l'aldéhyde ramifié est d'au moins 10:1, et dans lequel le groupe alcényle est un groupe allyle.</claim-text></claim><claim id="c-fr-01-0008" num="0008"><claim-text>Procédé selon l'une quelconque des revendications 6 à 7, dans lequel le ligand est :
<chemistry id="chem0013" num="0013"><img id="ib0015" file="imgb0015.tif" wi="87" he="51" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-fr-01-0009" num="0009"><claim-text>Procédé selon l'une quelconque des revendications 1 à 8, dans lequel l'alcool dans l'étape (c) est le méthanol ou l'éthanol.</claim-text></claim><claim id="c-fr-01-0010" num="0010"><claim-text>Procédé selon la revendication 9, dans lequel l'alcool est le méthanol.</claim-text></claim><claim id="c-fr-01-0011" num="0011"><claim-text>Procédé selon l'une quelconque des revendications 1 à 10, dans lequel la déprotection se produit par le biais de l'ajout d'un réactif de déprotection choisi parmi une base aqueuse, une amine ou une hydrazine.</claim-text></claim><claim id="c-fr-01-0012" num="0012"><claim-text>Procédé selon la revendication 11, dans lequel le réactif de déprotection est la méthylamine.</claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
